SiliconANGLE

[the voice of enterprise and emerging tech]

OUR NETWORK

Home
TechForward Awards
Cloud
- Cloud Native
AI
Security
Infra
Blockchain
Big Data
Emerging Tech
Policy
Apps
Iot
Women In Tech
theCUBE Research
Special Reports
Video Exclusives
CUBE SPECIAL FEATURES
RECENT CUBE EVENTS
AWARDS

METABOLOMICS

AI

Enveda Biosciences raises $130M to advance AI-driven drug discovery from natural compounds

BY DUNCAN RILEY - 1 YEAR AGO

CUBE EVENT COVERAGE

LATEST FROM THECUBE

Metadata management moves to the center of AI scale challenges

Unstructured data forces a rethink of enterprise AI platforms

Hybrid cloud moves from infrastructure choice to AI execution layer

Nutanix builds for enterprise AI as infrastructure turns hybrid

Enterprise AI adoption, demystified: What enterprises learned building with Google Cloud

DIVE INTO DAVE VELLANTE’S BREAKING ANALYSIS SERIES

2026 data predictions: Scaling AI agents via contextual intelligence

Nvidia resets the economics of AI factories, again

Why Nvidia maintains its moat and Gemini won’t kill OpenAI

Grading our 2025 enterprise technology predictions

Worker-bee AGI: Why AWS is betting on practical agents, not 'messiah AGI'

Sign Up for Our Weekly Newsletter

UPCOMING CUBE EVENTS

RECENT CUBE EVENTS

CES 2026

AWS re:Invent 2025

Microsoft Ignite 2025

SC25

Refresh North America 2025

2026 SiliconANGLE Media Inc. All rights reserved.

JOIN OUR COMMUNITY
- theCUBE
- theCUBE Research

Send us a News Tip

Name*
First Last
Type of Pitch*
Email*
What's your story?*
File
Email
This field is for validation purposes and should be left unchanged.

SIGN IN

...

Remember me

Forgot Password?

OR

New User? SIGN UP

...

...

SIGN UP

...

...

Bio

Ethics Statement

EXTRACT THE SIGNAL FROM THE NOISE

Like Free Content? Subscribe to follow.

CONTACT US

CONTACT US

NAME OF INDIVIDUAL*
NAME OF COMPANY*
EMAIL*
COMMENTS*

CONTACT US

NAME OF INDIVIDUAL*
NAME OF COMPANY*
EMAIL*
COMMENTS*

Cookies

We employ the use of cookies. Find out more.